1. Protocol Nο.: HOVON 124 WM/ECWM-R2
A prospective phase I/II trial of the combination of ixazomib citrate, rituximab and dexamethasone in patients with relapsed or progressive Waldenström's macroglobulinemia
Study Locations in Greece:
Department of Clinical Therapeutics, «Alexandra» Hospital, Athens
2. ECMW-1:DRC with or without once-weekly subcutaneous bortezomib
Study Locations in Greece:
Department of Clinical Therapeutics, «Alexandra» Hospital, Athens
3. BEIGENE
A Phase 3, Randomized, Open-Label, Multicenter Study Comparing the Efficacy and Safety of the Bruton's Tyrosine Kinase (BTK) Inhibitors BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM)
Study Locations in Greece:
Department of Clinical Therapeutics, «Alexandra» Hospital, Athens
4. HO-164 (in symptomatic relapsed WM )
Study Locations in Greece:
Department of Clinical Therapeutics, «Alexandra» Hospital, Athens